Pfizer, BioNTech launch trial for potential omicron-busting vaccine

Pfizer and BioNTech are launching a new clinical trial to test a potential omicron-busting COVID-19 vaccine.

The new vaccine will be included in a three-cohort study that will also examine different regimens of the companies’ existing COVID-19 shot, Comirnaty, according to a Tuesday press release.